BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai N, Jie H, Duan Y, Xiong P, Xu X, Chen P, Kang M, Li M, Li T, Huang Z, Chen H. Different serum protein factor levels in first-episode drug-naive patients with schizophrenia characterized by positive and negative symptoms. Psychiatry Clin Neurosci 2020;74:472-9. [PMID: 32478952 DOI: 10.1111/pcn.13078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Gao X, Bai X, Yao S, Chang YZ, Gao G. The emerging role of furin in neurodegenerative and neuropsychiatric diseases. Transl Neurodegener 2022;11:39. [PMID: 35996194 DOI: 10.1186/s40035-022-00313-1] [Reference Citation Analysis]
2 Zhou J, Zhou D, Yan T, Chen W, Xie H, Xiong Y. Association between CpG island DNA methylation in the promoter region of RELN and positive and negative types of schizophrenia. J Int Med Res 2022;50:3000605221100345. [PMID: 35638503 DOI: 10.1177/03000605221100345] [Reference Citation Analysis]
3 Dunleavy C, Elsworthy RJ, Upthegrove R, Wood SJ, Aldred S. Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatr Scand 2022. [PMID: 35202480 DOI: 10.1111/acps.13416] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
4 Liu Y, Song X, Liu X, Pu J, Gui S, Xu S, Tian L, Zhong X, Zhao L, Wang H, Liu L, Xu G, Xie P. Alteration of lipids and amino acids in plasma distinguish schizophrenia patients from controls: A targeted metabolomics study. Psychiatry Clin Neurosci 2021;75:138-44. [PMID: 33421228 DOI: 10.1111/pcn.13194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Prestwood TR, Asgariroozbehani R, Wu S, Agarwal SM, Logan RW, Ballon JS, Hahn MK, Freyberg Z. Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia. Behav Brain Res 2021;402:113101. [PMID: 33453341 DOI: 10.1016/j.bbr.2020.113101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]